Strategic Partnership PathNet has recently partnered with Alpenglow Biosciences to develop 3D pathology-based diagnostics for prostate and bladder cancers, presenting a collaborative upsell opportunity to integrate your digital pathology capabilities with their advanced diagnostic workflows.

Digital Workflow Expansion PathNet emphasizes digital workflow efficiencies that extend from the lab into clinic workflows, suggesting a sales angle around interoperable LIMS and EHR integrations, faster tissue processing, and improved turnaround times to attract clinics aiming to enhance patient throughput.

Oncology Focus Recognition as a Top 10 Oncology Solutions Provider and alignment with cancer diagnostics indicates potential opportunities to offer specialized digital pathology modules, AI-assisted analysis, and protocol standardization tailored for oncology practices.

Growth and Scale Range With 11-50 employees and annual revenue in the mid-range of several hundred million in the market, PathNet sits between boutique and mid-market labs, suggesting a fit for scalable cloud-based analytics, remote pathology signout, and modular service packages.

Competitive Positioning Compared to large reference labs, PathNet’s lean structure and niche focus on digital pathology allows for personalized demonstrations, faster pilots, and flexible contracting, making it a strong candidate for pilots with regional clinics and specialty centers.